Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in ...

Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though ...

The Food and Drug Administration (FDA) has cleared diabetes-management firm DexCom's (DXCM) new continuous glucose monitoring ...

In the search for better ways to treat diabetes, researchers at the University of Geneva have uncovered a promising new ...

A study led by two undergraduate students at the University of Galway found that GLP-1 receptor agonists, a type of diabetes ...

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors, may be linked to a reduced ...

Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

Researchers reviewed data from more than 56 million pregnancies to examine the connection between diabetes and A.D.H.D., ...